Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2007

01-06-2007 | CASE REPORT

Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and C

Authors: Zeki Karasu, Fatih Tekin, Galip Ersoz, Fulya Gunsar, Yucel Batur, Tankut Ilter, Ulus S. Akarca

Published in: Digestive Diseases and Sciences | Issue 6/2007

Login to get access

Abstract

Thrombocytopenia is a common complication of chronic liver diseases, but its pathogenesis is not clear. Although generally attributed to hypersplenism, other factors should also be considered. We investigated the relationship between the peripheral platelet count and the degree of fibrosis in patients with chronic viral hepatitis. In an effort to avoid the effects of hypersplenism, we excluded patients with splenomegaly and/or bi- or pan-cytopenia. Seven hundred eighty-four patients (265 chronic viral hepatitis C and 519 chronic viral hepatitis B) were included in the study. Univariate analysis showed that the peripheral platelet count had a negative correlation with fibrosis score, necroinflammatory activity, and age in both groups. In multivariate analysis, the peripheral platelet count had a similar correlation with the fibrosis score and age, but not with necroinflammatory activity, in both groups. The peripheral platelet count decreased more significantly in females with chronic hepatitis C but not in the chronic hepatitis B group. In conclusion, a decrease in peripheral platelet count may be a sign of an increase in the degree of fibrosis during the course of chronic viral hepatitis B and C and factors other than hypersplenism may play a role in this decrease in the peripheral platelet count.
Literature
1.
go back to reference Morlock CG, Hall BE (1943) Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69–77 Morlock CG, Hall BE (1943) Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69–77
2.
go back to reference Felix WR Jr, Myerson RM, Sigel B, Perrin EB, Jackson FC (1974) The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 139:899–903PubMed Felix WR Jr, Myerson RM, Sigel B, Perrin EB, Jackson FC (1974) The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 139:899–903PubMed
3.
go back to reference Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:70CrossRef Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:70CrossRef
4.
go back to reference Morris PW, Patton TB, Balint JA, Hirschowitz BI (1962) Portal hypertension, congestive splenomegaly, and portacaval shunt. Gastroenterology 42:555–559 Morris PW, Patton TB, Balint JA, Hirschowitz BI (1962) Portal hypertension, congestive splenomegaly, and portacaval shunt. Gastroenterology 42:555–559
5.
go back to reference Mutchnick MG, Lerner E, Conn HO (1980) Effect of portacaval anastamosis on hypersplenism. Dig Dis Sci 25:929–938PubMedCrossRef Mutchnick MG, Lerner E, Conn HO (1980) Effect of portacaval anastamosis on hypersplenism. Dig Dis Sci 25:929–938PubMedCrossRef
6.
go back to reference Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P (1977) The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605–612PubMedCrossRef Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P (1977) The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605–612PubMedCrossRef
7.
go back to reference Frick V (1967) Thrombocytopenie und lebercirrhose. Scweiz Med Wochens 97:407–413 Frick V (1967) Thrombocytopenie und lebercirrhose. Scweiz Med Wochens 97:407–413
8.
go back to reference Fiore LD, Brophy MT, Deykin D (2003) Hemostasis. In: Zackim D, Boyer TD (eds) Hepatology: A textbook of liver disease. 4th edn. pp 562–563 Fiore LD, Brophy MT, Deykin D (2003) Hemostasis. In: Zackim D, Boyer TD (eds) Hepatology: A textbook of liver disease. 4th edn. pp 562–563
9.
go back to reference Omata M (1998) Screening for hepatocellular carcinoma. In: Advances in therapeutic hepatology: A word view. Postgraduate course book. University of Chicago Press, Chicago, pp. 49–53 Omata M (1998) Screening for hepatocellular carcinoma. In: Advances in therapeutic hepatology: A word view. Postgraduate course book. University of Chicago Press, Chicago, pp. 49–53
10.
go back to reference Moschcowitz E (1948) The pathogenesis of splenomegaly in hypertension of the portal circulation: “congestive splenomegaly.” Medicine 27:187–221PubMed Moschcowitz E (1948) The pathogenesis of splenomegaly in hypertension of the portal circulation: “congestive splenomegaly.” Medicine 27:187–221PubMed
11.
go back to reference Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25:417–422PubMedCrossRef Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25:417–422PubMedCrossRef
12.
go back to reference de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Interrelationships between platelet count, platelet IgG, serum IgG, immune-complexes and severity of liver disease. Clin Lab Haematol 13:127–135PubMedCrossRef de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Interrelationships between platelet count, platelet IgG, serum IgG, immune-complexes and severity of liver disease. Clin Lab Haematol 13:127–135PubMedCrossRef
13.
go back to reference Skootsky SA, Rosove MH, Langley MB (1986) Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555–557PubMedCrossRef Skootsky SA, Rosove MH, Langley MB (1986) Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555–557PubMedCrossRef
14.
15.
go back to reference Wehmeier A, Scharf RE, Schneider W (1990) Influence of splenectomy on platelet morphometry and function. Klin Wochenschr 68:847–852PubMedCrossRef Wehmeier A, Scharf RE, Schneider W (1990) Influence of splenectomy on platelet morphometry and function. Klin Wochenschr 68:847–852PubMedCrossRef
16.
go back to reference Thomas HC, McSween RN, White RG (1973) Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288–1291PubMedCrossRef Thomas HC, McSween RN, White RG (1973) Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288–1291PubMedCrossRef
18.
go back to reference Kew MC (1996) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16:395–406PubMed Kew MC (1996) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16:395–406PubMed
19.
go back to reference MacPherson AI, Innes J (1953) Peripheral blood picture after operation for portal hypertension. Lancet 1:1120–1123PubMedCrossRef MacPherson AI, Innes J (1953) Peripheral blood picture after operation for portal hypertension. Lancet 1:1120–1123PubMedCrossRef
20.
go back to reference Vang J, Simert G, Hansson JA, Thylen U, Bengmark TS (1977) Results of a modified distal spleno–renal shunt for portal hypertension. Ann Surg 185:224–228PubMedCrossRef Vang J, Simert G, Hansson JA, Thylen U, Bengmark TS (1977) Results of a modified distal spleno–renal shunt for portal hypertension. Ann Surg 185:224–228PubMedCrossRef
21.
go back to reference Sullivan BH Jr, Tumen HJ (1961) The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 55:598–603PubMed Sullivan BH Jr, Tumen HJ (1961) The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 55:598–603PubMed
22.
go back to reference Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H (2000) Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45:1971–1976. Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H (2000) Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45:1971–1976.
23.
go back to reference Patton TB, Johnston CG, Lyons C, Jordan P Jr (1959) Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block. Am J Gastroenterol 32:291–310PubMed Patton TB, Johnston CG, Lyons C, Jordan P Jr (1959) Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block. Am J Gastroenterol 32:291–310PubMed
24.
go back to reference Puttini M, Marni A, Montes F, Belli L (1979) Effect of portasystemic shunt on hypersplenism: Clinical study in 129 patients with cirrhosis. Am Surg 45:444–448PubMed Puttini M, Marni A, Montes F, Belli L (1979) Effect of portasystemic shunt on hypersplenism: Clinical study in 129 patients with cirrhosis. Am Surg 45:444–448PubMed
25.
go back to reference Ferrara J, Ellison EC, Martin EW Jr, Cooperman M (1979) Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570–573PubMed Ferrara J, Ellison EC, Martin EW Jr, Cooperman M (1979) Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570–573PubMed
27.
go back to reference Marni A, Trojsi C, Belli L (1981) Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372–376 Marni A, Trojsi C, Belli L (1981) Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372–376
28.
go back to reference LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL (1993) Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420PubMed LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL (1993) Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420PubMed
29.
go back to reference Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM (1995) Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575–1580CrossRef Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM (1995) Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575–1580CrossRef
30.
go back to reference Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M (1996) Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134–137PubMed Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M (1996) Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134–137PubMed
31.
go back to reference Sungaran R, Markovic B, Chong BH (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101–107PubMed Sungaran R, Markovic B, Chong BH (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101–107PubMed
32.
go back to reference Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA (1997) Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285–288PubMed Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA (1997) Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285–288PubMed
33.
go back to reference Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127–131PubMedCrossRef Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127–131PubMedCrossRef
34.
go back to reference Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H (1998) Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907–913PubMed Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H (1998) Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907–913PubMed
35.
go back to reference Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S (1998) Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755–759PubMedCrossRef Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S (1998) Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755–759PubMedCrossRef
36.
go back to reference Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S (1989) Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180–183PubMedCrossRef Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S (1989) Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180–183PubMedCrossRef
37.
go back to reference Hutchison DE, Genton E, Porter KA, Daloze PM, Huguet C, Brettschneider L, Groth CG, Starzl TE (1968) Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27–33PubMed Hutchison DE, Genton E, Porter KA, Daloze PM, Huguet C, Brettschneider L, Groth CG, Starzl TE (1968) Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27–33PubMed
38.
go back to reference Rinkes IH, Van der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT (1991) Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126–1128 Rinkes IH, Van der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT (1991) Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126–1128
39.
go back to reference Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida Y, Shiina S, Omata M (1999) Platelet count reflects stage of chronic hepatitis C. Hepatol Res 15:192–200CrossRef Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida Y, Shiina S, Omata M (1999) Platelet count reflects stage of chronic hepatitis C. Hepatol Res 15:192–200CrossRef
40.
go back to reference Matsumuro H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y (2000) Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C—a study of 527 patients at one establishment. J Viral Hepat 7:268–275CrossRef Matsumuro H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y (2000) Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C—a study of 527 patients at one establishment. J Viral Hepat 7:268–275CrossRef
41.
go back to reference Okubo M, Shiota G, Kawasaki H (2000) Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond) 99:207–214CrossRef Okubo M, Shiota G, Kawasaki H (2000) Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond) 99:207–214CrossRef
42.
go back to reference Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142–3146PubMedCrossRef Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142–3146PubMedCrossRef
43.
go back to reference Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435PubMedCrossRef Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435PubMedCrossRef
44.
go back to reference Fusegawa H, Shiraishi K, Ogasawara F, Shimizu M, Haruki Y, Miyachi H, Matsuzaki S, Ando Y (2002) Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 27:101–106PubMed Fusegawa H, Shiraishi K, Ogasawara F, Shimizu M, Haruki Y, Miyachi H, Matsuzaki S, Ando Y (2002) Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 27:101–106PubMed
Metadata
Title
Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and C
Authors
Zeki Karasu
Fatih Tekin
Galip Ersoz
Fulya Gunsar
Yucel Batur
Tankut Ilter
Ulus S. Akarca
Publication date
01-06-2007
Published in
Digestive Diseases and Sciences / Issue 6/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9144-y

Other articles of this Issue 6/2007

Digestive Diseases and Sciences 6/2007 Go to the issue

Letter to the Editor

A Fulminant Enterocolitis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.